News
KALA Bio completes enrollment in CHASE trial, advancing KPI-012 for treating persistent corneal epithelial defects. Topline ...
Dr. Nicholas James shares why it’s important to identify which patients with high-risk, non-metastatic prostate cancer will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback